On the one hand, they are responsible for autoimmune disorders that involve inflammation and tissue injury; on the other hand, they can kill tumor cells in the same way as do TNFα and the Tag7–Hsp70 complex, thereby showing an antitumor activity. Here, PGLYRP1 is linked to autoimmune disease.